Insights

Innovative Therapeutics Smart Immune specializes in advanced thymus-empowered T cell therapies, offering cutting-edge solutions for cancer and infectious diseases, which positions it uniquely in the next-generation immunotherapy market.

Significant Funding Backing The company has attracted notable investments, including a $5 million grant from the Bill & Melinda Gates Foundation and €17.5 million in EU funding, signaling strong validation of its technology and potential for accelerated growth.

Clinical Development Stage With ongoing Phase I/II trials in cancer and immune deficiencies, Smart Immune presents opportunities to collaborate on clinical trials, supply research equipment, or provide specialized diagnostic tools.

Expanding Leadership Recent high-profile appointments such as a new Chief Medical Officer enhance its credibility and open avenues for partnerships with healthcare providers and research institutions seeking innovative treatments.

Emerging Market Position Recognized as Best Startup in Pharmaceutical Biotechnology, Smart Immune is gaining industry recognition, making it a potential partner for distribution channels, investors, or strategic alliances looking to tap into innovative biotech solutions.

Similar companies to Smart Immune

Smart Immune Tech Stack

Smart Immune uses 8 technology products and services including imgix, Axeptio, styled-components, and more. Explore Smart Immune's tech stack below.

  • imgix
    Content Delivery Network
  • Axeptio
    Cookie Compliance
  • styled-components
    Javascript Frameworks
  • OVHcloud
    Platform As A Service
  • Lua
    Programming Languages
  • Yoast SEO
    Search Engines
  • Google Search Console
    Web Analytics
  • OpenResty
    Web Servers

Media & News

Smart Immune's Email Address Formats

Smart Immune uses at least 1 format(s):
Smart Immune Email FormatsExamplePercentage
First.Last@smart-immune.comJohn.Doe@smart-immune.com
94%
FirstLast@smart-immune.comJohnDoe@smart-immune.com
3%
First.Middle@smart-immune.comJohn.Michael@smart-immune.com
3%

Frequently Asked Questions

Where is Smart Immune's headquarters located?

Minus sign iconPlus sign icon
Smart Immune's main headquarters is located at 29 Rue du Faubourg Saint-jacques Paris, Île-de-france 75014 France. The company has employees across 2 continents, including EuropeNorth America.

What is Smart Immune's official website and social media links?

Minus sign iconPlus sign icon
Smart Immune's official website is smart-immune.com and has social profiles on LinkedInCrunchbase.

What is Smart Immune's SIC code NAICS code?

Minus sign iconPlus sign icon
Smart Immune's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Smart Immune have currently?

Minus sign iconPlus sign icon
As of May 2026, Smart Immune has approximately 14 employees across 2 continents, including EuropeNorth America. Key team members include Ceo And Co Founder: K. R.Chief Medical Officer: A. R. F.Communication Manager: P. R.. Explore Smart Immune's employee directory with LeadIQ.

What industry does Smart Immune belong to?

Minus sign iconPlus sign icon
Smart Immune operates in the Biotechnology Research industry.

What technology does Smart Immune use?

Minus sign iconPlus sign icon
Smart Immune's tech stack includes imgixAxeptiostyled-componentsOVHcloudLuaYoast SEOGoogle Search ConsoleOpenResty.

What is Smart Immune's email format?

Minus sign iconPlus sign icon
Smart Immune's email format typically follows the pattern of First.Last@smart-immune.com. Find more Smart Immune email formats with LeadIQ.

How much funding has Smart Immune raised to date?

Minus sign iconPlus sign icon
As of May 2026, Smart Immune has raised $5M in funding. The last funding round occurred on Apr 16, 2023 for $5M.

When was Smart Immune founded?

Minus sign iconPlus sign icon
Smart Immune was founded in 2017.

Smart Immune

Biotechnology ResearchÎle-de-france, France11-50 Employees

Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T cell progenitors through its ProTcell platform to provide targeted treatments like off-the-shelf CAR T. The Company is headquartered in Paris, France, at Paris Biotech Santé.

Section iconCompany Overview

Headquarters
29 Rue du Faubourg Saint-jacques Paris, Île-de-france 75014 France
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $5M

    Smart Immune has raised a total of $5M of funding over 5 rounds. Their latest funding round was raised on Apr 16, 2023 in the amount of $5M.

  • $1M$10M

    Smart Immune's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $5M

    Smart Immune has raised a total of $5M of funding over 5 rounds. Their latest funding round was raised on Apr 16, 2023 in the amount of $5M.

  • $1M$10M

    Smart Immune's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.